Healthcare PharmaceuticalsMenhibrix
Owned by GSK plc
Combination vaccine (Hib-MenCY-TT) developed by GlaxoSmithKline for prevention of meningococcal disease (serogroups C and Y) and invasive Haemophilus influenzae type b disease in infants. FDA approved June 14, 2012. Discontinued in the US market.
vaccinemeningococcalhaemophilus-influenzae